These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10917084)

  • 1. Oral contraceptives and venous thromboembolism. New Zealand Committee, RANZCOG. Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
    N Z Med J; 2000 May; 113(1110):196. PubMed ID: 10917084
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives.
    Vandenbrouke JP; Bloemenkamp KW; Rosendaal FR; Helmerhorst FM
    BMJ; 2000 Jan; 320(7226):57-8. PubMed ID: 10671043
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.
    Jick H
    BMJ; 2000 Jan; 320(7226):57; author reply 57-8. PubMed ID: 10617543
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 5. Do third-generation oral contraceptives (OCs) increase the risk of venous thrombosis?
    Sapp AV; Lindbloom EJ
    J Fam Pract; 2001 Oct; 50(10):893. PubMed ID: 11674894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
    Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract]   [Full Text] [Related]  

  • 7. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DoH seems to have underestimated incidence of venous thromboembolism in users of combined oral contraceptives.
    Lawrenson RA; Whalley A; Simpson E; Farmer RD
    BMJ; 1999 Aug; 319(7206):387. PubMed ID: 10435982
    [No Abstract]   [Full Text] [Related]  

  • 9. Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertainty.
    Maling TJ
    N Z Med J; 1999 Aug; 112(1094):305-7. PubMed ID: 10493438
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology on trial.
    Barton A
    Lancet; 2002 Nov; 360(9345):1612. PubMed ID: 12443647
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiology on trial.
    de Laat W; Raff WK
    Lancet; 2002 Nov; 360(9345):1611-2. PubMed ID: 12443645
    [No Abstract]   [Full Text] [Related]  

  • 12. Coat of arms of The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG).
    Winspear R
    Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):2. PubMed ID: 15730356
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral contraceptives and venous thromboembolism.
    Roke C
    N Z Med J; 1999 Nov; 112(1099):436. PubMed ID: 10678237
    [No Abstract]   [Full Text] [Related]  

  • 14. [Venous thromboembolism and combined oral contraceptives. Reported adverse reactions indicate at least similar risk with the most recent contraceptive pills].
    Kieler H; Persson I; Odlind V
    Lakartidningen; 2003 Sep; 100(39):3050-2. PubMed ID: 14560670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Third generation oral contraceptives and risk of venous thrombosis--the English lesson].
    Sørensen MB
    Ugeskr Laeger; 2002 Apr; 164(18):2418; author reply 2418-9. PubMed ID: 12024851
    [No Abstract]   [Full Text] [Related]  

  • 16. Yasmin--an oral contraceptive with a new progestin.
    Med Lett Drugs Ther; 2002 Jun; 44(1133):55-7. PubMed ID: 12080274
    [No Abstract]   [Full Text] [Related]  

  • 17. Is it time to drop royal patronage of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists?
    Nicklin J; Robertson G
    Aust N Z J Obstet Gynaecol; 2023 Aug; 63(4):603-605. PubMed ID: 37555704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies.
    Emmerich J; Thomassin C; Zureik M
    J Thromb Haemost; 2014 Sep; 12(9):1388-90. PubMed ID: 25041638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2004 Jun; 124(11):1521-2. PubMed ID: 15195157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.